Company intelligence / Profile preview
Hualan Biological Engineering Inc.
- Ownership
- Private
- Development stage
- Commercial
Overview
Hualan Biological Engineering is a leading Chinese biopharmaceutical company with multiple approved products including vaccines and blood products. The company has completed Phase 3 clinical trials for human prothrombin complex for hemophilia B treatment.
- Therapeutic areas
- HematologyInfectious Diseases
- Modalities
- VaccinesBlood ProductsRecombinant ProteinsMonoclonal Antibodies
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Hualan Biological Engineering Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hualan Biological Engineering Inc..